Literature DB >> 7703364

Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat.

J Alary1, F Bravais, J P Cravedi, L Debrauwer, D Rao, G Bories.   

Abstract

4-Hydroxy-2-nonenal (HNE), an aldehyde end product of lipid peroxidation in biological systems, is capable of producing a range of powerful biological effects. Despite its biological relevance, the metabolic fate of this aldehyde is unknown in vivo. This study examines the urinary excretion of HNE in the rat and the nature of metabolites formed. Following iv administration of [3H]HNE, the majority of the dose appeared in urine (67.1% after 48 h). The radio-HPLC metabolic profile showed that no unchanged parent compound was detected in urine whereas at least four metabolites were present, most of them corresponding to mercapturic acid conjugates. Two major pathways were involved in the biotransformation of HNE in vivo: (i) reduction/oxidation of the aldehyde group, and (ii) conjugation to endogenous glutathione leading to mercapturic acid conjugates in urine. These end products were isolated by HPLC and identified by mass spectrometry as HNE mercapturic acid, 1,4-dihydroxynonene mercapturic acid, 4-hydroxynonenoic mercapturic acid, and the corresponding lactone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703364     DOI: 10.1021/tx00043a004

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  27 in total

Review 1.  Urinary biomarkers of oxidative status.

Authors:  Dora Il'yasova; Peter Scarbrough; Ivan Spasojevic
Journal:  Clin Chim Acta       Date:  2012-06-07       Impact factor: 3.786

2.  A synthesis of 4-hydroxy-2-trans-nonenal and 4-(3H) 4-hydroxy-2-trans-nonenal.

Authors:  A Chandra; S K Srivastava
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

3.  Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane.

Authors:  X Gao; A T Dinkova-Kostova; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.

Authors:  S Srivastava; A Chandra; L F Wang; W E Seifert; B B DaGue; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

5.  Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency.

Authors:  X Luo; S Pitkänen; S Kassovska-Bratinova; B H Robinson; D C Lehotay
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress.

Authors:  Heather C Kuiper; Jan F Stevens
Journal:  Curr Protoc Toxicol       Date:  2011-02-01

Review 7.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

8.  4-Hydroxy-2(E)-nonenal enantiomers: (S)-selective inactivation of glyceraldehyde-3-phosphate dehydrogenase and detoxification by rat glutathione S-transferase A4-4.

Authors:  A Hiratsuka; K Hirose; H Saito; T Watabe
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

9.  Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver.

Authors:  Sushabhan Sadhukhan; Yong Han; Zhicheng Jin; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2014-02-18       Impact factor: 7.376

10.  Synthesis of 9,9,9-trideutero-1,4-dihydroxynonane mercapturic acid (d3-DHN-MA), a useful internal standard for DHN-MA urinalysis.

Authors:  B Chantegrel; C Deshayes; A Doutheau; J P Steghens
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.